Pediatric Heart Transplantation in Human Leukocyte Antigen–Sensitized Patients: Evolving Management and Assessment of Intermediate-Term Outcomes in a High-Risk Population
暂无分享,去创建一个
[1] S. Webber,et al. Anti‐HLA alloantibodies in pediatric solid organ transplantation , 2006, Pediatric transplantation.
[2] S. Jordan,et al. Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA‐Sensitized Patients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] K. Mussatto,et al. The virtual crossmatch – A screening tool for sensitized pediatric heart transplant recipients , 2006, Pediatric transplantation.
[4] Gerald J Berry,et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] S. Dunlap,et al. The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome , 2005, Transplantation.
[6] S. Mital,et al. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[7] R. Graff,et al. Use of rituximab to decrease panel-reactive antibodies. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] S. Gandhi,et al. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. , 2005, Human immunology.
[9] R. Shaddy,et al. The sensitized pediatric heart transplant candidate: Causes, consequences, and treatment options , 2005, Pediatric transplantation.
[10] N. Smedira,et al. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. , 2005, Transplantation proceedings.
[11] J. Jacobs,et al. Pediatric cardiac transplantation in children with high panel reactive antibody. , 2004, The Annals of thoracic surgery.
[12] W. Mahle,et al. Panel-reactive antibody cross-reactivity and outcomes in the pediatric heart transplant study group , 2004 .
[13] H. Eisen,et al. Cardiac transplantation across a positive prospective lymphocyte cross‐match in sensitized recipients , 2003, Clinical transplantation.
[14] M. Mehra,et al. Allosensitization in heart transplantation: implications and management strategies , 2003, Current opinion in cardiology.
[15] D. McKenna,et al. HLA alloimmunization in patients requiring ventricular assist device support. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] R. Shaddy,et al. Immunology and failure of valved allografts in children. , 2002, The Annals of thoracic surgery.
[17] A. Brand. Immunological aspects of blood transfusions. , 2002, Transplant immunology.
[18] John J. Chen,et al. Panel-reactive antibody screening practices prior to heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] S. Takemoto,et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. , 2000, Transplantation.
[20] S. Takemoto,et al. Anti-HLA antibodies after solid organ transplantation. , 2000, Transplantation.
[21] M. Oz,et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. , 1999, Circulation.
[22] J. A. Robinson,et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] K. Osborne,et al. Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts. , 1997, The American journal of cardiology.
[24] B. Griffith,et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] J. Bergin,et al. Management of patients with preformed reactive antibodies who are awaiting cardiac transplantation. , 2005, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[26] Silviu Itescu,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[27] E. Roseau. [ABO-incompatible heart transplantation in infants]. , 2001, Presse medicale.
[28] M. Wilhelm,et al. Chronic rejection. , 1998, Transplantation proceedings.